Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Anti-CD45 Monoclonal Antibody (MAb) Dose Optimization For Astatine-211 ( 211 At)-Radioimmunotherapy (RIT) Of Relapsed Non-Hodgkin Lymphoma (NHL) In a Canine Model
Blood (2013)
  • Erlinda B. Santos, Fred Hutchinson Cancer Research Center
  • Brian W. Miller, Pacific Northwest National Laboratory
  • Tom A. Bäck, University of Gothenburg
  • Donald K. Hamlin, University of Washington
  • D. Scott Wilbur, University of Washington
  • Aimee L. Kenoyer, Fred Hutchinson Cancer Research Center
  • Shani L. Frayo, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • Rainer Storb, Fred Hutchinson Cancer Research Center
  • Brenda M. Sandmaier, University of Washington
  • John M. Pagel, University of Washington
Link
Disciplines
Publication Date
November 15, 2013
Citation Information
Erlinda B. Santos, Brian W. Miller, Tom A. Bäck, Donald K. Hamlin, et al.. "Anti-CD45 Monoclonal Antibody (MAb) Dose Optimization For Astatine-211 ( 211 At)-Radioimmunotherapy (RIT) Of Relapsed Non-Hodgkin Lymphoma (NHL) In a Canine Model" Blood Vol. 122 Iss. 21 (2013) p. 5139 - 5139
Available at: http://works.bepress.com/john-pagel/117/